197 related articles for article (PubMed ID: 37612283)
1. Androgen receptor binding sites enabling genetic prediction of mortality due to prostate cancer in cancer-free subjects.
Ito S; Liu X; Ishikawa Y; Conti DD; Otomo N; Kote-Jarai Z; Suetsugu H; Eeles RA; Koike Y; Hikino K; Yoshino S; Tomizuka K; Horikoshi M; Ito K; Uchio Y; Momozawa Y; Kubo M; ; Kamatani Y; Matsuda K; Haiman CA; Ikegawa S; Nakagawa H; Terao C
Nat Commun; 2023 Aug; 14(1):4863. PubMed ID: 37612283
[TBL] [Abstract][Full Text] [Related]
2. Incidence of androgen receptor and androgen receptor variant 7 coexpression in prostate cancer.
Vellky JE; Bauman TM; Ricke EA; Huang W; Ricke WA
Prostate; 2019 Dec; 79(16):1811-1822. PubMed ID: 31503366
[TBL] [Abstract][Full Text] [Related]
3. PRState: Incorporating genetic ancestry in prostate cancer risk scores for men of African ancestry.
Pagadala MS; Linscott JA; Talwar JV; Seibert TM; Rose B; Lynch J; Panizzon M; Hauger R; Hansen MH; Sammon JD; Hayn MH; Kader K; Carter H; Ryan ST
BMC Cancer; 2022 Dec; 22(1):1289. PubMed ID: 36494783
[TBL] [Abstract][Full Text] [Related]
4. Androgen hormone action in prostatic carcinogenesis: stromal androgen receptors mediate prostate cancer progression, malignant transformation and metastasis.
Ricke EA; Williams K; Lee YF; Couto S; Wang Y; Hayward SW; Cunha GR; Ricke WA
Carcinogenesis; 2012 Jul; 33(7):1391-8. PubMed ID: 22535887
[TBL] [Abstract][Full Text] [Related]
5. A genome-wide association study of prostate cancer in Latinos.
Du Z; Hopp H; Ingles SA; Huff C; Sheng X; Weaver B; Stern M; Hoffmann TJ; John EM; Van Den Eeden SK; Strom S; Leach RJ; Thompson IM; Witte JS; Conti DV; Haiman CA
Int J Cancer; 2020 Apr; 146(7):1819-1826. PubMed ID: 31226226
[TBL] [Abstract][Full Text] [Related]
6. Length and somatic mosaicism of CAG and GGN repeats in the androgen receptor gene and the risk of prostate cancer in men with benign prostatic hyperplasia.
Tayeb MT; Clark C; Murray GI; Sharp L; Haites NE; McLeod HL
Ann Saudi Med; 2004; 24(1):21-6. PubMed ID: 15310009
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
Zaia A; Fraizer GC; Piantanelli L; Saunders GF
Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
[TBL] [Abstract][Full Text] [Related]
8. AR imposes different effects on ZFHX3 transcription depending on androgen status in prostate cancer cells.
Fu X; Zhang Z; Liu M; Li J; A J; Fu L; Huang C; Dong JT
J Cell Mol Med; 2022 Feb; 26(3):800-812. PubMed ID: 34953044
[TBL] [Abstract][Full Text] [Related]
9. Identification of Potential Genes for Benign Prostatic Hyperplasia and Prostate Cancer Susceptibility in Four X-chromosome Regions with High Frequency of Microvariant Alleles.
Albujja MH; Messaudi SA; Vasudevan R; Al Ghamdi S; Chong PP; Ghani KA; Ranneh Y; Alaidarous M; Ismail P
Asian Pac J Cancer Prev; 2020 Aug; 21(8):2271-2280. PubMed ID: 32856855
[TBL] [Abstract][Full Text] [Related]
10. Polygenic risk scores for the prediction of common cancers in East Asians: A population-based prospective cohort study.
Ho PJ; Tan IB; Chong DQ; Khor CC; Yuan JM; Koh WP; Dorajoo R; Li J
Elife; 2023 Mar; 12():. PubMed ID: 36971353
[TBL] [Abstract][Full Text] [Related]
11. Association of prostate cancer risk with SNPs in regions containing androgen receptor binding sites captured by ChIP-On-chip analyses.
Lu Y; Sun J; Kader AK; Kim ST; Kim JW; Liu W; Sun J; Lu D; Feng J; Zhu Y; Jin T; Zhang Z; Dimitrov L; Lowey J; Campbell K; Suh E; Duggan D; Carpten J; Trent JM; Gronberg H; Zheng SL; Isaacs WB; Xu J
Prostate; 2012 Mar; 72(4):376-85. PubMed ID: 21671247
[TBL] [Abstract][Full Text] [Related]
12. Tissue-specific quantification and localization of androgen and estrogen receptors in prostate cancer.
Sehgal PD; Bauman TM; Nicholson TM; Vellky JE; Ricke EA; Tang W; Xu W; Huang W; Ricke WA
Hum Pathol; 2019 Jul; 89():99-108. PubMed ID: 31054895
[TBL] [Abstract][Full Text] [Related]
13. Validation of a multi-ancestry polygenic risk score and age-specific risks of prostate cancer: A meta-analysis within diverse populations.
Chen F; Darst BF; Madduri RK; Rodriguez AA; Sheng X; Rentsch CT; Andrews C; Tang W; Kibel AS; Plym A; Cho K; Jalloh M; Gueye SM; Niang L; Ogunbiyi OJ; Popoola O; Adebiyi AO; Aisuodionoe-Shadrach OI; Ajibola HO; Jamda MA; Oluwole OP; Nwegbu M; Adusei B; Mante S; Darkwa-Abrahams A; Mensah JE; Adjei AA; Diop H; Lachance J; Rebbeck TR; Ambs S; Gaziano JM; Justice AC; Conti DV; Haiman CA
Elife; 2022 Jul; 11():. PubMed ID: 35801699
[TBL] [Abstract][Full Text] [Related]
14. Identification of novel androgen receptor target genes in prostate cancer.
Jariwala U; Prescott J; Jia L; Barski A; Pregizer S; Cogan JP; Arasheben A; Tilley WD; Scher HI; Gerald WL; Buchanan G; Coetzee GA; Frenkel B
Mol Cancer; 2007 Jun; 6():39. PubMed ID: 17553165
[TBL] [Abstract][Full Text] [Related]
15. Early human prostate adenocarcinomas harbor androgen-independent cancer cells.
Fiñones RR; Yeargin J; Lee M; Kaur AP; Cheng C; Sun P; Wu C; Nguyen C; Wang-Rodriguez J; Meyer AN; Baird SM; Donoghue DJ; Haas M
PLoS One; 2013; 8(9):e74438. PubMed ID: 24086346
[TBL] [Abstract][Full Text] [Related]
16. Combined Cell-free DNA and RNA Profiling of the Androgen Receptor: Clinical Utility of a Novel Multianalyte Liquid Biopsy Assay for Metastatic Prostate Cancer.
Fettke H; Kwan EM; Docanto MM; Bukczynska P; Ng N; Graham LK; Mahon K; Hauser C; Tan W; Wang XH; Zhao Z; Zheng T; Zhou K; Du P; Yu J; Huang Y; Jia S; Kohli M; Horvath LG; Azad AA
Eur Urol; 2020 Aug; 78(2):173-180. PubMed ID: 32487321
[TBL] [Abstract][Full Text] [Related]
17. Lipid nanoparticles to silence androgen receptor variants for prostate cancer therapy.
Quick J; Santos ND; Cheng MHY; Chander N; Brimacombe CA; Kulkarni J; van der Meel R; Tam YYC; Witzigmann D; Cullis PR
J Control Release; 2022 Sep; 349():174-183. PubMed ID: 35780952
[TBL] [Abstract][Full Text] [Related]
18. miR-103a-2-5p/miR-30c-1-3p inhibits the progression of prostate cancer resistance to androgen ablation therapy via targeting androgen receptor variant 7.
Chen W; Yao G; Zhou K
J Cell Biochem; 2019 Aug; 120(8):14055-14064. PubMed ID: 30963631
[TBL] [Abstract][Full Text] [Related]
19. Collocation of androgen receptor gene mutations in prostate cancer.
Buchanan G; Greenberg NM; Scher HI; Harris JM; Marshall VR; Tilley WD
Clin Cancer Res; 2001 May; 7(5):1273-81. PubMed ID: 11350894
[TBL] [Abstract][Full Text] [Related]
20. The combination of the prodrugs perforin-CEBPD and perforin-granzyme B efficiently enhances the activation of caspase signaling and kills prostate cancer.
Chuang CH; Wang WJ; Li CF; Ko CY; Chou YH; Chuu CP; Cheng TL; Wang JM
Cell Death Dis; 2014 May; 5(5):e1220. PubMed ID: 24810056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
